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Abstract The transient receptor potential-like ion channel from
Drosophila melanogaster was originally identified as a cal-
modulin binding protein (Philips et al., 1992) involved in the
dipterian phototransduction process. We used a series of fusion
proteins and an epitope expression library of transient receptor
potential-like fusion proteins to characterize calmodulin binding
regions in the transient receptor potential-like channel through
the use of [125I]calmodulin and biotinylated calmodulin and
identified two distinct sites at the C-terminus of the transient
receptor potential-like ion channel. Calmodulin binding site 1,
predicted from searching of the primary structure for amphiphilic
helices (Philips et al., 1992), covers a 16 amino acid sequence
(S710^I725) and could only be detected through biotinylated
calmodulin. Calmodulin binding site 2 comprises at least 13
amino acids (K859ETAKERFQRVAR871) and binds both
[125I]calmodulin and biotinylated calmodulin. Both sites (i) bind
calmodulin at least in a one to one stoichiometry, (ii) differ in
their affinity for calmodulin revealing apparent Ki values of
12.3 nM (calmodulin binding site 1) and 1.7 nM (calmodulin
binding site 2), respectively, (iii) bind calmodulin only in the
presence of Ca2+ with 50% of site 1 and site 2, respectively,
occupied by calmodulin in the presence of 0.1 WM (calmodulin
binding site 1) and 3.3 WM Ca2+ (calmodulin binding site 2) and
give evidence that (iv) a Ca2+-calmodulin-dependent mechanism
contributes to transient receptor potential-like cation channel
modulation when expressed in CHO cells.
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1. Introduction
Two photoreceptor cell-speci¢c gene products have been
isolated from Drosophila melanogaster which have been impli-
cated to be light sensitive ion channels involved in the inver-
tebrate phototransduction process [2,3]. The transient receptor
potential (trp) gene product is a protein of 1275 amino acids
[4,5] with multiple transmembrane domains and when ex-
pressed in vitro, leads to an increased Ca2 conductance
which is activated after the depletion of intracellular Ca2
stores by inositol 1,4,5-trisphosphate (InsP3) or thapsigargin
[6^9]. The transient receptor potential-like (trpl) gene is 49%
identical to TRP over the N-terminal 850 amino acids [1] and
encodes a non-selective cation channel [10,11,12].
The trpl gene was initially isolated in a screen for calmodu-
line (CaM) binding proteins from a Drosophila head cDNA
expression library [1]. As a result of searching the amino acid
sequence for amphiphilic K-helices, TRPL was originally
postulated to contain two CaM binding sites in its C-terminal
domain [1] and in the following, it was shown that a synthetic
peptide representing the predicted CaM binding site 1
(CaMBS1) of TRPL binds CaM in a Ca2-dependent manner
[13]. The predicted CaM binding site 2 (CaMBS2) was local-
ized to amino acids 809^825 [1,14], although there is exper-
imental evidence that CaMBS2 is localized within a 43 amino
acid sequence from residue 853 to residue 895 of TRPL [13].
This second site was shown to bind the Ca2-free form of
CaM [13]. In contrast to these experiments, the results of
recent in vivo studies implicate that TRPL light-activated
channels are modulated by Ca2-CaM [15] and that in intact
Drosophila photoreceptor cells, TRPL channels bind CaM
only in the presence of Ca2 [15]. These ¢ndings prompted
us to characterize in detail the distinct localization of CaM
binding sequences present in TRPL and their potential Ca2-
dependency. We now report Ca2-dependent CaM binding to
the TRPL protein employing three experimental approaches,
that are CaM overlay assays, mobility shift assays and CaM-
sepharose chromatography. In addition, we mapped CaMBS2
to 13 amino acid residues within the TRPL protein and show
that both sites, CaMBS1 and CaMBS2, di¡er in their a⁄nities
for CaM and bind CaM at least in a one to one stoichiometry.
Using a somatic cell line stably expressing the TRPL cation
channel [12], we also show that the CaM antagonist cal-
midazolium inhibits the Ca2-dependent activation of TRPL
currents indicating TRPL channel modulation by intracellular
Ca2 via CaM.
2. Materials and methods
2.1. Materials
Puri¢ed phosphodiesterase (PDE1A2) was generously provided by
W.K. Sonnenburg and J.A. Beavo, Department of Pharmacology,
University of Washington (Seattle, WA, USA), the Drosophila trpl
cDNA by M. Phillips, Department of Genetics, University of
Melbourne. Various materials and reagents were obtained from the
following suppliers: 2.8-[3H]cGMP from Amersham; [K-35S]dATP
(1000 Ci/mmol) and 125I-Bolton Hunter-labelled CaM (83.4 WCi/Wg)
from DuPont NEN; nitrocellulose sheets from Schleicher and
Schuell; pGEX-2T and CaM-sepharose from Pharmacia Biotech; bo-
vine brain CaM, biotinylated bovine brain CaM, calmidazolium and
streptavidin alkaline phosphatase conjugate from Calbiochem; SDS-
PAGE standards, Crotulus atrox snake venom, DEAE sephadex
A25 anion exchange resin and cGMP from Sigma. Peptides corre-
sponding to amino acid residues CaMBS1-(710^725)-SVKWVIRIF-
RKSSKTI, CaMBS2-(854^875)-PSKPAKETAKERFQRVARTVLL,
CaMBS2-(859^871)-KETAKERFQRVAR and B42d-(7^20)-LPTGV-
SSGVHASSA of the TRPL protein were synthesized at the Institut
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fu«r Pharmakologie und Toxikologie, Technische Universita«t Mu«n-
chen. All other reagents were of the highest purity grade available.
2.2. Constructs for expression of glutathion S-transferase (GST) fusion
proteins
All recombinant DNA manipulations were carried out using stand-
ard procedures [16]. Fusion protein epitopes of TRPL [1] were con-
structed by amplifying base pairs 2278^2625 (a), 2392^3525 (b) and
1945^2496 (c) covering amino acid residues 709^825 (a), 747e1124 (b)
and 598e782 (c), respectively, with the following primers: 5P-CGG
GAT CCG TCA AGT GGG TCA TC-3P, 5P-CGG AAT TCT CAC
GCC ACC TGG AAG CCC TT-3P, 5P-CGG GAT CCC TGG TTT
GGC GAT AT-3P, 5P-CGG AAT TCT TAG TTT CGA TGC TTT
GG-3P, 5P-CGG AAT TCC TAA CGC ATC GTA TTG ATC TC-3P
and 5P-CGG GAT CCC ACG GAG ACT CCT GCA TG-3P. The
resulting PCR products were digested with BamHI and EcoRI, sub-
cloned in the pGEX-2T vector and sequenced on both strands by the
dideoxy chain termination method using [K-35S]dATP [17]. Recombi-
nant pGEX vectors were introduced into Escherichia coli BL21 cells
and protein expression was carried out as described previously [18].
Afterwards, proteins were separated electrophoretically in 12% SDS-
polyacrylamide gels according to [19].
2.3. Protein transfer to nitrocellulose and CaM overlay experiments
The resolved proteins were transferred to nitrocellulose membranes
(0.45 Wm) at 0.8 mA/cm2 for 80 min. For detection of [125I]CaM
binding proteins, the nitrocellulose membranes were incubated with
10 mM imidazole, pH 7.4, 150 mM KCl, 1 mM CaCl2, 0.2% Tween
20 (bu¡er A) and 5% non-fat dry milk for 1 h at 21‡C, followed by
overlay with [125I]CaM (3.5U106 cpm/ml bu¡er A and 5% dry milk)
for 4 h at 21‡C. Membranes were washed with bu¡er A three times
for 10 min at 21‡C. Bound [125I]CaM binding proteins were visualized
by autoradiography. For detection of proteins binding biotinylated
CaM, the nitrocellulose membranes were incubated with 50 mM
Tris-HCl, pH 7.4, 150 mM NaCl, 50 mM MgCl2, 500 WM CaCl2
(bu¡er B) and 10% non-fat dry milk for 1 h, followed by overlay
with biotinylated CaM (100 ng/ml bu¡er B and 10% dry milk) for
2 h at 21‡C. The nitrocellulose membranes were washed three times
for 10 min with bu¡er B and then incubated in the presence of strep-
tavidin-alkaline phosphatase at a dilution of 1:1000 in bu¡er B for
30 min. The membranes were then washed three times for 10 min in
bu¡er B followed by a wash in 100 mM Tris-HCl, pH 9.5, 100 mM
NaCl, 50 mM MgCl2 and 500 WM CaCl2 (bu¡er C) and color was
developed with nitro blue tetrazolium and 5-bromo-4-chloro-indolyl
phosphate at 0.33 mg/ml and 0.175 mg/ml bu¡er C, respectively.
2.4. Construction and screening of a TRPL epitope library
Construction and screening of the TRPL epitope library was car-
ried out as described previously [18,20,21] except that TRPL cDNA
fragments of 50^150 bp length were electro-eluted. After construction
and expression of T7 Gen10 TRPL fusion proteins, bacterial colonies
were transferred on replica ¢lters, lysed and denatured and then, the
¢lters were blocked in bu¡er A containing 5% non-fat dry milk,
washed twice with the same solution followed by an incubation in
the presence of [125I]CaM (3.5U106 cpm/ml bu¡er A and 5% dry
milk) for 4^6 h at 21‡C. After washing three times in bu¡er A, the
¢lters were dried and exposed to a X-ray ¢lm (Hyper¢m MP, Amer-
sham). For isolation of single positive colonies, a re-screen was per-
formed and cDNA inserts of positive clones were sequenced on both
strands.
2.5. Phosphodiesterase assay
Phosphodiesterase assays in the presence or absence of synthetic
TRPL peptides CaMBS1-(710^725), CaMBS2-(854^875), CaMBS2-
(859^871) and B42d-(7^20) were carried out according to established
procedures [22] with the 61 kDa bovine PDE1A2 CaM-stimulated
cyclic nucleotide phosphodiesterase [23].
2.6. CaM-sepharose chromatography of synthetic peptides
30 nmol of synthetic peptides representing the CaM binding sites
were dissolved in 250 Wl bu¡er containing 50 mM Tris-HCl pH 7.3,
100 mM NaCl and the Ca2 concentrations described (‘Ca2 bu¡er’)
or 5 mM EGTA (‘Ca2-free bu¡er’), respectively, and then applied to
0.5 ml CaM-sepharose columns (V33 nmol CaM) pre-equilibrated in
the same bu¡ers. The Ca2 concentrations between 0.01 and 10 WM
were adjusted by adding EGTA or N-hydroxyethyletyhlenediaminetri-
acetic acid (HEDTA) according to Schoenmakers et al. [24]. The
columns were washed with 5^10 ml of the respective Ca2 bu¡er
followed by a wash with the ‘Ca2-free bu¡er’ to elute residual bound
peptides. All wash fractions were collected and the peptide concen-
trations determined by the BCA protein assay reagent kit (Pierce)
using the respective peptides as standards.
2.7. Mobility shift assay to study binding of the peptide to Ca2+-CaM
Mixtures of TRPL peptides and CaM ¢xed at 15 WM at di¡erent
molar ratios were incubated in 50 mM Tris-HCl pH 7.3, 250 mM
NaCl and either 1 mM CaCl2 or 2 mM EGTA and aliquots compris-
ing 3 Wg CaM were separated on gradient gels containing 5^20%
acrylamide and 375 mM Tris-HCl, pH 8.8, at 10 mA for 8^12 h at
4‡C. After electrophoresis, the gel was stained with Coomassie blue.
2.8. Electrophysiological measurements
Current recordings from a Chinese hamster ovary (CHO) cell line
stably expressing the TRPL cDNA [12] were carried out by using the
patch-clamp technique in the whole-cell con¢guration [25]. Pipettes
(Kimax: Kimble Products, Witz Scienti¢c, OH, USA) were pulled
to obtain resistances between 2.5 and 5 MW. The pipette solution
contained 7 WM free Ca2, 110 mM CsCl, 5.5 mM CaCl2, 3 mM
MgCl2, 10 mM EDTA and 5 mM HEPES, pH 7.2 (CsOH). Current
measurements were performed in bath solutions containing 115 mM
NaCl, 5 mM KCl, 10 mM CaCl2, 2 mM MgCl2, 5 mM HEPES, pH
7.4 (NaOH). Series resistances (Rs) and the whole-cell membrane ca-
pacitance (Cm) were read from the settings provided by the ampli¢er
after cancellation of transients occurring in the whole-cell con¢gura-
tion. Only current recordings from experiments with s 1 GW seal
resistance and a Rs lower than 10 MW were pooled for statistical
evaluations. Electronic compensation of about 50% was currently
used to improve the charging time.
3. Results and discussion
3.1. Localization of two CaM binding sites
To identify CaM binding sites in TRPL, we constructed
and expressed a number of GST fusion proteins that contain
fragments of TRPL covering the C-terminal half of the pro-
tein (Fig. 1A). [125I]CaM binding to these fusion proteins was
examined by an overlay procedure (Fig. 1B). Strong
[125I]CaM binding was detected in fusion protein b and deg-
radation products of protein b, but not in a and c. According
to these results, the C-terminal 300 amino acids of TRPL
appear to be su⁄cient to bind CaM but interestingly, they
do not include the amino acid sequences S710^R728 and
R809^A825, originally predicted to represent CaM binding sites
on the basis of sequence analysis [1].
In order to identify the precise localization of potential
CaM binding sites within the complete TRPL protein, an
epitope expression library of TRPL fusion proteins was con-
structed and screened with [125I]CaM as probe. 12 independ-
ent clones were identi¢ed and isolated. Sequence analysis re-
vealed that all clones contained cDNAs in the appropriate
reading frame and encoded peptide sequences containing
17^46 amino acids (Fig. 1C). The smallest epitope su⁄cient
to bind CaM was encoded by clone S15 (Fig. 1C), comprising
17 amino acids and extending from residue K859 to L875 of
TRPL. Interestingly, it contained 13 residues (amino acids
K859^R871) which were also included in the derived sequence
of the 12 other clones isolated, indicating that this 13 amino
acid sequence motif is su⁄cient for CaM binding. No clones
were obtained encoding peptide sequences derived from other
regions of the TRPL protein.
In previous studies, Warr and Kelly [13] gave evidence that
biotinylated CaM binds to two CaM binding sites within
TRPL covering amino acids 711^725 and a 43 amino acid
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sequence (residues 853^895 of TRPL) which they called
CaMBS1 and CaMBS2. The 13 amino acid peptide identi¢ed
by screening the TRPL epitope library with [125I]CaM in the
present study is part of the 43 amino acid peptide identi¢ed by
Warr and Kelly [13] and speci¢es further the amino acids of
CaMBS2 necessary to bind CaM. However, CaMBS1 could
not be detected using [125I]CaM as probe. Therefore, fusion
proteins c (GST fusion protein: MrV51 000, Fig. 1B) and S25
(epitope library clone, T7 Gen10 fusion protein: MrV40 000,
Fig. 1C) supposed to contain CaMBS1 and CaMBS2, respec-
tively, were expressed in E. coli and separated electrophoreti-
cally. Fig. 2A shows a Coomassie blue-stained gel of fusion
proteins S25 (BS2, left lane) and c (BS1, right lane), respec-
tively. Fig. 2B shows an autoradiograph of a blot prepared
from a similar gel as in Fig. 2A, but overlaid with [125I]CaM.
Strong [125I]CaM binding was detected in CaMBS2 (BS2) but
not in CaMBS1 (BS1). In contrast, when a second blot of a
similar gel was overlaid with biotinylated CaM, binding was
detected in both fusion proteins (Fig. 2C). Obviously, the
mode of interaction di¡ered in that CaM binding of CaMBS1
could only be detected by biotinylated CaM whereas site 2
binds both, biotinylated CaM and [125I]CaM. Iodination oc-
curs predominantly at lysine residues of CaM [26,27] and
the incorporation of 125I apparently disturbs CaM binding
to site 1.
3.2. Determination of the CaM-peptide complex stoichiometry
in the presence of calcium
In order to quantify the interaction between the binding
sites and Ca2-CaM, we synthesized two peptides, CaMBS1-
(710^725) and CaMBS2-(854^875). Binding of the peptides to
CaM was analyzed with a gel shift assay, in which a mixture
of the respective peptide and CaM was run on a non-denatur-
ing gel in the presence of Ca2 (Fig. 3). In the absence of the
peptides, there was a single band re£ecting pure Ca2-CaM.
At a ratio of CaMBS2-(854^875) to CaM of 0.25 or 0.5, two
bands were visible on the gel (Fig. 3A), a Ca2-CaM band
and another that migrated with a lower mobility, representing
the peptide-Ca2-CaM complex. When the ratio of peptide to
CaM was unity, the pure CaM band disappeared and the
peptide-CaM complex band concurrently increased in inten-
sity. At still higher ratios, no new bands appeared on the gel
suggesting that multivalent complexes were absent. Removal
of Ca2 by EGTA in a control experiment (data not shown)
abolished complex formation. These observations suggest that
CaMBS2-(854^875) binds CaM with a one to one stoichiom-
etry in a Ca2-dependent way. In contrast, using comparable
experimental conditions, no peptide-CaM complex was ob-
served using CaMBS1-(710^725) either in the absence or pres-
ence of Ca2 (Fig. 3B). Similar results as in Fig. 3B were
obtained after changing the experimental conditions including
elongation of electrophoresis time, electrophoresis at lower
Fig. 2. Expression of fusion proteins containing CaMBS1 and
CaMBS2 and detection of biotinylated CaM and [125I]CaM binding.
A: Coomassie blue staining of whole-cell lysates expressing fusion
proteins S25 (10 Wg, BS2) and c (100 Wg, BS1) containing CaMBS2
and CaMBS1, respectively, separated by 8% SDS-PAGE. B: An
autoradiograph of a blot from a gel similar to that presented in
(A), but overlaid with [125I]CaM in the presence of 1 mM Ca2.
C: A blot from a gel similar to that presented in A but overlaid
with biotinylated CaM in the presence of 1 mM Ca2. Arrows indi-
cate positions of CaMBS1 (C) and CaMBS2 (B, C).
Fig. 1. Identi¢cation of CaM binding sites of TRPL. A: Model of transmembrane topology of TRPL including the putative pore region
£anked by the putative ¢fth and sixth transmembrane segments is shown. Bar represents the C-terminal half of TRPL (S598^N1124) with the
protein region responsible for CaM binding indicated (A825^N1124). B: Bacterial lysates representing 50 Wg of protein and containing fusion
proteins a (lane 1), b (lane 2) and c (lane 3) and GST (lane 4), respectively, were separated by SDS-PAGE, transferred to nitrocellulose mem-
branes and overlaid with [125I]CaM in the presence of 1 mM Ca2. [125I]CaM binding (autoradiogram) occurs with GST fusion protein b, but
not to a, c or GST control (3). C: Alignment of amino acid sequences of fusion TRPL epitopes as deduced from the 12 independent clones
obtained by screening an epitope expression library of TRPL with [125I]CaM. Boxed letters represent the common 13 amino acid residues
(K859^R871) encoded by all clones and representing a minimal CaM binding site.
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voltages or an increase of the length of the incubation time of
CaMBS1-(710^725) and CaM in the absence or presence of
Ca2 prior to electrophoresis. These results suggest that
CaMBS1-(710^725) is unable to interact directly with CaM
under the conditions employed in these experiments.
3.3. Quantitation of binding a⁄nities of peptide-CaM
complexes
To get an estimate of the apparent potencies of CaM bind-
ing of the CaM binding sites CaMBS1 and CaMBS2, a com-
petition assay using the PDE1A2 CaM-stimulated cyclic nu-
cleotide phosphodiesterase was employed. PDE1A2 has a
basal activity for cGMP hydrolysis and can be activated by
CaM [23]. To determine which peptide most potently binds
CaM, PDE1A2 was assayed in the presence of 4 nM CaM
and peptide concentrations ranging between 100 pM and
10 WM (Fig. 4A). Peptide CaMBS2-(854^875) showed the
strongest inhibition with an IC50 of 2.78 þ 0.27 nM. The pep-
tide CaMBS2-(859^871) comprising the minimal CaM binding
motif of 13 amino acids was less potent having an IC50 value
of 340 þ 69 nM. Surprisingly, peptide CaMBS1-(710^725)
which did not show complex formation with CaM in the
mobility shift assay (Fig. 3B) now appears to bind to CaM.
The peptide competed with PDE1A2 for CaM with an appa-
rent IC50 value of 19.8 þ 2.3 nM. Peptide B42d-(7^20), cover-
ing amino acid residues 7^20 of TRPL was used as a negative
control. There is only a slight decrease of enzyme activity in
the presence of B42d-(7^20) (96%, Fig. 4A), indicating a spe-
ci¢c interaction of CaMBS peptides, CaM and PDE1A2. Ki
values according to the Cheng-Pruso¡ equation [28] were
12.3 þ 1.4, 1.7 þ 0.2 and 211 þ 43.3 nM for CaMBS1-(710^
725), CaMBS2-(854^875) and CaMBS2-(859^871), respec-
tively.
The inhibition of CaM-stimulated PDE1A2 activity by the
synthetic peptides can be caused by either competition of pep-
tides with PDE1A2 for CaM or a direct interaction of pep-
tides with PDE1A2. Addition of peptides CaMBS1 or
CaMBS2 at 100 nM inhibited the PDE activity stimulated
with 3 nM CaM (Fig. 4B). However, no inhibition by the
peptides was detected when an excess of CaM (240 nM) was
used to activate the PDE, indicating that the inhibition ob-
Fig. 4. A: inhibition potency of CaM-stimulated phosphodiesterase PDE1A2 activity by synthetic TRPL peptides. 2.44 nM of partially puri¢ed
bovine PDE1A2 was assayed with 100 pM to 10 WM synthetic peptide CaMBS1-(710^725), CaMBS2-(854^875), CaMBS2-(859^871) or B42d-
(7^20) in the presence of 0.2 mM CaCl2 and 4 nM CaM. Enzyme activity is expressed as the percentage of CaM-stimulated PDE1A2 activity
in the absence of synthetic peptides (activities ranges from 51 to 73 Wmol/min/mg protein). Values are presented as the mean of three assays
performed in triplicate. The IC50 values for peptides CaMBS1-(710^725), CaMBS2-(854^875) and CaMBS213 were 19.8 þ 2.3, 2.78 þ 0.27 and
340 þ 69 nM, respectively (x þ S.E.M). B: The ability of excess CaM to overcome inhibition of CaM-stimulated phosphodiesterase PDE1A2 ac-
tivity by synthetic peptides CaMBS2 and CaMBS1. Partially puri¢ed PDE1A2 was assayed in the presence of either 5 mM EGTA (white bars),
0.2 mM CaCl2 and 3 nM CaM (gray bars) or 0.2 mM CaCl2 and 240 nM CaM (black bars) and either no peptide or 100 nM synthetic pep-
tide CaMBS2 or CaMBS1. PDE1A2 activity is expressed as Wmol cGMP hydrolyzed/min/mg of protein. Values are the mean of triplicate deter-
minations. The S.E.M. (not shown) did not exceed 15% of the mean activity value.
Fig. 3. Binding of the CaMBS2 and CaMBS1 peptides to Ca2-
CaM studied in a gel mobility shift assay. Mixtures of peptides
CaMBS2-(854^875) (A) and CaMBS1-(710^725) (B) and CaM at
di¡erent molar ratios (with the CaM concentration ¢xed at 15 WM)
were incubated in the presence of 1 mM Ca2 for 30 min at 21‡C.
A portion of each mixture was then separated by non-denaturing
polyacrylamide gel electrophoresis in the presence of 1 mM Ca2
and proteins were stained by Coomassie blue. Being negatively
charged, CaM migrated toward the positive pole in the bottom of
the gel (A, lane 1). The complex formed (A, lanes 2^6 and B, lane
6) between CaMBS2-(854^875) and Ca2-CaM was stable during
electrophoresis and migrated with a lower mobility. No mobility
shift was observed in B (lanes 2^5) using di¡erent molar ratios of
CaM and the CaMBS1-(710^725) peptide.
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served is due to competition of the peptides with PDE1A2 for
CaM.
3.4. The e¡ect of the Ca2+ concentration on CaM binding
The experiments shown so far demonstrate that peptides
CaMBS1-(710^725), CaMBS2-(854^875) and CaMBS2-(859^
871) bind CaM. Previously, it has been suggested that at least
CaMBS2 binds the Ca2-free form of CaM, whereas CaMBS1
binds CaM in a Ca2-dependent fashion, requiring concentra-
tions above 0.3^0.5 WM for CaM binding [13]. In these experi-
ments [13], a peptide representing CaMBS1 and a fusion pro-
tein containing CaMBS2 were bound to CaM-sepharose in
100 WM Ca2 and then washed in the presence of decreasing
concentrations of Ca2 [13]. We performed a similar experi-
ment using the synthetic peptides CaMBS1-(710^725) and
CaMBS2-(854^875) and the results obtained are summarized
in Table 1. 91% of CaMBS1-(710^725) and 96% of CaMBS2-
(854^875) bound to CaM-sepharose in the presence of 100
WM Ca2, even after extensive washing of the column with
a Ca2 containing bu¡er. However, both peptides are almost
completely eluted by Ca2-free bu¡er (91% of bound
CaMBS1 and 97% of CaMBS2) indicating that CaMBS2 as
well as CaMBS1 bound CaM only in the presence of Ca2
ions.
In an extension of this experiment, equal amounts of
CaMBS1-(710^725) were bound to CaM-sepharose in the
presence of 10 WM, 1 WM, 0.5 WM, 0.3 WM, 0.1 WM and in
the absence of Ca2, respectively. After consecutive washes
with the corresponding Ca2 bu¡er and Ca2-free bu¡er,
the peptide concentrations in the respective wash solutions
were determined and the amount of bound peptide calculated.
CaM binding to CaMBS1-(710^725) (Fig. 5A triangles) de-
pends on the presence of Ca2 and maximal binding occurs
at a free Ca2 concentration of 1 WM. At 0.1 WM Ca2,
CaMBS1 is occupied by CaM at 50%. In these experiments,
almost equal amounts of CaM-sepharose (33 nmol) and pep-
tide (30 nmol) were employed and the results obtained indi-
cate that CaMBS1 binds CaM at least in a one to one stoi-
chiometry.
As has been demonstrated in the previous experiments em-
ploying CaM-sepharose, CaM binding to CaMBS2 depends
on the presence of Ca2. To study the Ca2-dependent bind-
ing of CaM to CaMBS2 in detail, the fusion protein S25,
containing CaMBS2 (Fig. 2C), was expressed in bacteria
and an overlay with [125I]CaM was performed. In the next
step, the ¢lter was incubated in the presence of [125I]CaM
and 100 WM Ca2 and in the following, the ¢lter was cut
into pieces, repeatedly washed with bu¡ers of various free
Ca2 concentrations and exposed to a X-ray ¢lm. The inten-
sities of the signals indicating the amount of [125I]CaM bound
to CaMBS2 (Fig. 5B) were analyzed by a phosphoimager and
blotted in Fig. 5A (CaMBS2, circles) against the free Ca2
concentration. At a free Ca2 concentration of 3.3 WM
(mean of two experiments), 50% of CaMBS2 is occupied by
[125I]CaM. In summary, these experiments demonstrate that
both sites within the TRPL channel protein bind CaM in a
Ca2-dependent way although binding of CaM to CaMBS2
occurs at 33-fold higher Ca2 concentrations than binding to
CaMBS1.
3.5. Ca2+-CaM-dependence of TRPL ion channel modulation
The CaM concentration within a cell is usually in the order
of 1 WM, exceeding the Ki values of CaMBS1 (12.3 nM) and
of CaMBS2 (1.7 nM) for CaM binding. In vivo, occupation of
both binding sites by CaM should therefore depend on the
cytosolic Ca2 concentration which oscillates between 0.1^
0.2 WM in a resting cell [29]. To study functional implications
of Ca2-dependent CaM binding, the cDNA of the TRPL
channel protein was stably expressed in a CHO cell line [12]
and currents through TRPL channels were recorded with the
patch-clamp technique in the whole-cell mode. In this expres-
sion system, TRPL currents are enhanced by a rise of the
cytosolic Ca2 concentration [12]. In contrast, while keeping
cellular Ca2 bu¡ered with EGTA to 6 50 nM, the TRPL
current is not detectable [12]. Saturation of the channel activ-
ity occurs at 1.5^3 WM cytosolic Ca2 with an apparent EC50
value of 450 nM for the Ca2-dependent activation [12]. This
EC50 value is very similar to the Ca2 concentrations of
0.1 and 3.3 WM required for CaM binding to TRPL (Fig.
Table 1
The e¡ect of the Ca2 concentration on CaM binding
Peptide Bu¡er Recovery from CaM-sepharose
CaMBS1-(710^725) Ca2 9%
Ca2-free 91%
CaMBS2-(854^875) Ca2 4%
Ca2-free 97%
30 nmol of peptide CaMBS1-(710^725) or peptid CaMBS2-(854^
875), respectively, was bound to V33 nmol CaM-sepharose, pre-
equilibrated in ‘Ca2 bu¡er’ (100 WM Ca2) or ‘Ca2-free bu¡er’
(5 mM EGTA), respectively. Columns were washed with 10^20 vol-
umes of the appropriate bu¡er. The columns equilibrated with
‘Ca2 bu¡er’ were additionally washed with ‘Ca2-free bu¡er’ to
elute residual bound peptide. All wash fractions were collected and
peptide concentrations were determined. Recovery of peptide in the
wash fractions is expressed as the percentage of the total peptide
applied (100%). Values represent means of two experiments.
Fig. 5. The e¡ect of the Ca2 concentration on CaM binding to
CaMBS1 and CaMBS2. A: Binding of CaM to CaMBS1 (triangles)
or CaMBS2 (circles) in the absence and presence of increasing con-
centrations of Ca2 is shown. CaM binding to CaMBS1 was exam-
ined by CaM-sepharose chromatography. B: [125I]CaM binding to
CaMBS2 was quanti¢ed by phosphoimager analysis. EC50 values of
Ca2-dependent CaM binding to CaMBS1 and CaMBS2 were
0.1 and 3.3 WM, respectively (mean of two and three determinations,
respectively). Binding is expressed as percentage of maximal bind-
ing.
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5A), indicating that Ca2-dependent CaM binding modulates
the TRPL channel function.
Fig. 6 shows traces of current densities elicited by voltage
ramps from 380 to +80 mV. When CHO (trpl) cells [12] are
incubated for 30 min in the presence of the CaM antagonist
calmidazolium (2 WM), the enhancement of TRPL currents
induced by dialysis of V7 WM Ca2 is markedly reduced
(Fig. 6). By increasing the calmidazolium concentration to
12 WM, the TRPL channel activity is almost completely abol-
ished since the current densities recorded under these condi-
tions essentially re£ect leak background levels of CHO cells
(Fig. 6). Although the native channel may bind CaM in a
di¡erent way than the isolated CaM binding sites, the Ca2-
dependent modulation of the expressed TRPL channel [12]
and the in£uence of the Ca2 antagonist calmidazolium on
this modulation (Fig. 6) argues in favor of a similar behavior
of the CaM binding sites in the native channel compared with
the behavior of the isolated sites.
In Drosophila phototransduction, CaM has been implicated
to coordinate termination of the light response by modulating
receptor and ion channel activity [15]. In addition to TRPL,
other members of this signal transduction system are capable
of CaM binding, such as TRP [30], the ryanodin receptor [31]
or the inactivation no after-depolarization (INAD) gene prod-
uct [30]. The ¢nding that Ca2-dependent modulation of
TRPL currents [12] is prevented in the presence of the CaM
antagonist calmidazolium (Fig. 6) gives additional evidence
for Ca2-CaM-dependent mechanisms underlying this proc-
ess. In future experiments, it will be necessary to analyze the
CaM function by expressing forms of the TRPL channel in
which mutations have been introduced into the CaM binding
sites, which have been characterized in this study. Further-
more, the mechanisms leading to inactivation of TRPL chan-
nels have not been de¢ned and it was suggested [32] that the
latter process might require another protein not necessarily
present in the cell lines used so far for heterologous expression
of TRPL cDNA. TRPL and TRP bind CaM and, in vivo,
both proteins and possibly yet to be identi¢ed additional dip-
terian products of this gene family may assemble into homo-
and/or heteromultimeric complexes [3,9,33]. It will be of in-
terest to analyze the contribution of Ca2-CaM upon the
function of such complexes. The knowledge of the Ca2-de-
pendent CaM interaction with TRPL will facilitate this anal-
ysis.
Trp and trpl are archetypal members of a multigene family
whose products share a structure that is highly conserved
throughout evolution, from yeast to mammals. So far, at least
seven mammalian TRP/TRPL homologous ion channels have
been identi¢ed and one may speculate that some of them if
not all are also capable of CaM binding.
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